Extracorporeal Membrane Oxygenation System Market Size, Share, Growth, and Industry Analysis, By Type (Veno-Arterial (VA),Veno-Venous (VV),Arterio-Venous (AV)), By Application (Respiratory,Cardiac,Extracorporeal Cardiopulmonary Resuscitation (ECPR)), Regional Insights and Forecast to 2035

Extracorporeal Membrane Oxygenation System Market Overview

The global Extracorporeal Membrane Oxygenation System Market size is projected to grow from USD 486.56 million in 2026 to USD 528.06 million in 2027, reaching USD 1016.45 million by 2035, expanding at a CAGR of 8.53% during the forecast period.

The Extracorporeal Membrane Oxygenation System Market has shown significant advancement as demand for advanced life support technologies has increased by 32% in critical care units globally. With over 58% of hospitals in developed economies adopting ECMO systems, usage in neonatal, pediatric, and adult cases has expanded rapidly. In 2023, more than 47% of ECMO procedures were performed in North America, while Asia-Pacific accounted for 29% of procedures due to rising cardiac and respiratory cases. 

In the USA, more than 61% of ECMO installations are in top-tier hospitals, with 37% focused on adult applications and 24% dedicated to neonatal care. ECMO use in the USA has increased by 18% year-on-year, with more than 11,000 patients treated annually using ECMO devices. States such as California, Texas, and New York account for 42% of national ECMO procedures, while investment in training programs has risen by 15% to address skilled workforce demand.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Increasing prevalence of respiratory and cardiac disorders influencing 47% of new ECMO system installations globally.
• Major Market Restraint: High operational costs restrict 36% of smaller healthcare facilities from adopting ECMO technologies.
• Emerging Trends: Portable ECMO devices account for 28% of new installations in hospitals and mobile intensive care units.
• Regional Leadership: North America holds 41% share of ECMO system usage, followed by Europe with 33% adoption.
• Competitive Landscape: Top five companies dominate 62% of the global ECMO market with strong product portfolios.
• Market Segmentation: Adult ECMO cases represent 52% of demand, neonatal 29%, and pediatric applications 19% globally.
• Recent Development: 34% growth in government funding programs aimed at ECMO infrastructure development in 2024.

Extracorporeal Membrane Oxygenation System Market Latest Trends

The Extracorporeal Membrane Oxygenation System Market has been strongly influenced by new technological developments, with 39% of hospitals integrating advanced oxygenators into their ECMO setups. Portable ECMO systems now represent 27% of installations, particularly favored in emergency and transport cases. The adoption of artificial intelligence for ECMO monitoring has grown by 22%, reducing complication rates in over 15% of patients.

Hybrid ECMO systems that combine multiple functionalities account for 18% of all new purchases by hospitals, reflecting a shift toward efficiency and patient-centered designs. Additionally, 46% of healthcare organizations are investing in staff training programs, ensuring a higher standard of ECMO use across intensive care units. Rising prevalence of respiratory failure cases, which increased by 31% over the last decade, further fuels adoption. 

Extracorporeal Membrane Oxygenation System Market Dynamics

DRIVER

"Rising demand for advanced cardiopulmonary support"

Demand for extracorporeal membrane oxygenation has surged as 49% of intensive care units report increased reliance on ECMO for critical cardiopulmonary cases. More than 54% of patients with severe respiratory distress now receive ECMO interventions in specialized centers. In Europe, ECMO utilization has grown by 23% due to rising cardiovascular disease prevalence, while Asia-Pacific reported a 27% increase. 

RESTRAINT

"High operational and training costs"

Despite its clinical importance, ECMO adoption is limited as 38% of healthcare providers cite high operational costs as a barrier. Training requirements are also extensive, with 41% of facilities highlighting insufficient trained staff as a major issue. In developing nations, only 19% of hospitals have the capacity to maintain ECMO systems due to infrastructure limitations. Disposable supplies for ECMO contribute to 28% of total operational expenses, discouraging smaller healthcare providers. 

OPPORTUNITY

"Integration of portable and AI-based ECMO systems"

Advances in portable ECMO systems present an opportunity, with adoption growing by 26% in mobile emergency units. Artificial intelligence integration has reduced complication risks by 17% and improved efficiency by 21% in real-time monitoring. North America has seen 43% of ECMO centers integrating AI-supported platforms, while Europe recorded 31%. Pediatric hospitals adopting compact ECMO units increased by 28%, showing significant growth opportunities. 

CHALLENGE

"Rising costs and infrastructure demands"

One of the major challenges is rising infrastructure costs, with 37% of hospitals reporting budget constraints in setting up ECMO facilities. Implementation requires specialized rooms, contributing to 29% higher capital expenditure compared to conventional systems. In low-resource countries, only 14% of hospitals have sufficient infrastructure for ECMO deployment. A shortage of perfusionists and ECMO specialists has been reported by 42% of healthcare providers globally, further restricting adoption. 

Extracorporeal Membrane Oxygenation System Market Segmentation

The Extracorporeal Membrane Oxygenation System Market is segmented by type into veno-venous (VV) and veno-arterial (VA), accounting for 62% and 36% of installed base respectively, with other modes at 2%. By application, adult cases represent 58% of procedures, neonatal accounts for 19%, and pediatric comprises 23%. Oxygenator components capture 44% of spend, pumps 31%, and cannulae 25%. 

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Polarized: Polarized sunglasses address glare reduction for 76% of outdoor sports users, with adoption in fishing, sailing, and skiing communities above 64%. Premium coatings feature in 57% of SKUs, and photochromic-polarized hybrids reach 18% of assortments. Retail conversion rises by 21% for polarized displays, and returns are 13% lower due to 28% higher perceived visual comfort. Online penetration is 38%, with average selling prices 22% above category norms. Lens materials split 49% TAC, 41% polycarbonate, and 10% glass. 

The polarized sunglasses segment is estimated at USD 12.50 billion in 2025, representing 44% category share, supported by premium positioning and sports adoption, advancing at a 7.1% CAGR on sustained outdoor and travel participation.

Top 5 Major Dominant Countries in the Polarized Segment

• USA: The USA polarized market totals USD 3.10 billion with 24.8% segment share and 6.8% CAGR, reflecting 41% sports usage, 36% premium mix, and 52% specialty optical channel contribution across coastal and mountain leisure regions.
• China: China achieves USD 2.35 billion, 18.8% share, and 8.2% CAGR, driven by 44% e-commerce penetration, 29% commuter glare reduction need, and expanding domestic brands holding 38% of polarized mid-tier inventory nationwide.
• Japan: Japan records USD 1.10 billion, 8.8% share, and 5.1% CAGR, supported by 47% urban commuter adoption, 33% fishing and marine activities, and retail price premia averaging 19% over non-polarized alternatives across major prefectures.
• Germany: Germany posts USD 0.95 billion, 7.6% share, and 4.9% CAGR, underpinned by 54% automotive glare usage, 31% cycling segment reliance, and optical chains accounting for 58% of polarized sell-through nationwide.
• Italy: Italy reaches USD 0.82 billion, 6.6% share, and 4.4% CAGR, with 43% tourism-linked purchases, 37% fashion-luxury mix, and domestic lens craftsmanship influencing 28% of polarized SKU introductions annually.

Non-polarized: Non-polarized sunglasses dominate mass retail with 56% unit share and 41% price accessibility advantage versus polarized. Fashion cycles drive 39% of seasonal volume, while festival and leisure events add 14% uplift. Polycarbonate lenses make up 67% of units, metal frames 28%, and acetate 26% (multi-material overlap). UV400 compliance stands at 92%. Fast-fashion assortments rotate every 6–8 weeks, refreshing 31% of shelf space. Youth and unisex styles account for 63% of purchases. 

The non-polarized sunglasses segment is valued at USD 15.90 billion in 2025, equal to 56% share worldwide, expanding at a 4.6% CAGR supported by fashion turnover, accessibility, and broad multi-channel distribution coverage.

Top 5 Major Dominant Countries in the Non-polarized Segment

• USA: USA non-polarized sales hit USD 3.60 billion, 22.6% share, and 4.1% CAGR, propelled by 48% department and variety channels, 33% festival-season spikes, and private-label contributions above 29% of annual unit throughput.
• China: China records USD 3.10 billion, 19.5% share, and 5.2% CAGR, led by 58% marketplace penetration, 27% influencer-driven conversions, and urban tier-2/3 consumer clusters contributing 46% of incremental demand each quarter.
• India: India delivers USD 1.45 billion, 9.1% share, and 6.0% CAGR, with 61% youth adoption, 43% value-price bands, and 37% seasonal promotions linked to summer peaks and major festival shopping windows nationwide.
• Brazil: Brazil achieves USD 0.88 billion, 5.5% share, and 4.7% CAGR, buoyed by 52% beach-leisure usage, 36% convenience retail, and 28% impulse purchasing at transport hubs across coastal states and major metropolitan regions.
• Germany: Germany totals USD 0.85 billion, 5.3% share, and 3.8% CAGR, supported by 41% fashion-forward assortments, 35% optical chains’ private brands, and 29% of sales originating from seasonal discounting periods.

BY APPLICATION

Sun Specialty Stores: Sun specialty stores command strong service differentiation with 63% of fittings assisted by trained staff, lifting conversion by 24%. Polarized mix reaches 54% here, with premium AR and hydrophobic coatings utilized in 51% of prescriptions. Custom lens edging and adjustments are performed on 46% of purchases, reducing returns by 17%. Loyalty programs cover 37% of active customers, adding 22% higher lifetime value. In-store diagnostics and UV demonstrations influence 28% of undecided shoppers.

Sun specialty stores represent USD 9.09 billion, or 32% share, advancing at 5.1% CAGR, supported by premium fittings, expert consultation, and elevated attachment of coatings and prescription upgrades.

Top 5 Major Dominant Countries in the Sun Specialty Stores Application

• USA: USA specialty-store sunglasses total USD 2.60 billion, 28.6% share, and 4.9% CAGR, with 58% polarized mix, 43% lens-service attachments, and coastal metros generating 39% of premium traffic and conversion gains.
• China: China posts USD 1.55 billion, 17.1% share, and 6.1% CAGR, driven by 41% premiumization, 36% urban mall locations, and 27% membership programs delivering repeat purchases and higher per-visit spend.
• Italy: Italy achieves USD 0.68 billion, 7.5% share, and 4.2% CAGR, reflecting 48% fashion-luxury orientation, 33% tourist flow concentration, and optical boutiques accounting for 57% of specialty sell-through.
• Japan: Japan reaches USD 0.66 billion, 7.3% share, and 3.9% CAGR, with 52% commuter focus, 37% high-index lens uptake, and meticulous fittings elevating satisfaction scores by 18% over general retail.
• France: France delivers USD 0.59 billion, 6.5% share, and 4.1% CAGR, supported by 45% polarized-premium mix, 31% insurance-linked prescriptions, and flagship stores contributing 29% of annual specialty revenues.

Resorts: Resorts drive experiential purchasing with 64% of transactions influenced by on-site sunshine exposure and 29% by immediate leisure needs. Resort boutiques prioritize polarized at 57% of mix and travel-friendly cases in 46% of bundles. Impulse purchase rates are 33% higher than urban retail, while limited-edition capsule launches lift average selling price by 19%. Cross-selling with sunscreen and hats adds 22% to basket value. International visitors constitute 41% of buyers in peak seasons. Branded displays near pools and beaches increase visibility by 38%, and concierge referrals capture 16% of store footfall.

Resorts contribute USD 3.98 billion, equating to 14% share, growing at 5.8% CAGR on the back of travel recovery, experiential retailing, and impulse-led accessory purchases across coastal and alpine destinations.

Top 5 Major Dominant Countries in the Resorts Application

• USA: USA resort sunglasses reach USD 1.15 billion, 28.9% share, and 5.2% CAGR, with 46% coastal resort influence, 32% desert/leisure locales, and capsule drops raising seasonal ASPs by 17% across destination properties.
• Spain: Spain totals USD 0.49 billion, 12.3% share, and 5.7% CAGR, driven by 58% beach resort concentration, 27% international visitor purchases, and polarized comprising 55% of units in Balearic and Canary destinations.
• Mexico: Mexico posts USD 0.44 billion, 11.0% share, and 6.3% CAGR, with 61% Caribbean-coast sales, 34% duty-paid resort boutiques, and bundled accessories contributing 24% of transaction value growth.
• Thailand: Thailand delivers USD 0.36 billion, 9.1% share, and 6.1% CAGR, reflecting 63% island-resort traffic, 39% Asian tourist mix, and seasonal promotions boosting conversion by 21% in Phuket and Samui hubs.
• UAE: UAE achieves USD 0.33 billion, 8.3% share, and 6.0% CAGR, with 57% luxury resort influence, 44% tourist spending, and curated polarized assortments delivering 29% higher margins in beachfront properties.

Hotels: Hotel retail emphasizes convenience, with 47% of sunglasses sales occurring within 24 hours of check-in. Lobby stores capture 38% of transactions, while poolside kiosks account for 29%. Multipacks and travel cases appear in 41% of baskets. Corporate travel contributes 23% of midweek volume, vacationers 77%. Average price points trail resorts by 12% but exceed convenience retail by 18%. Late-night availability boosts impulse purchases by 16%. Partnerships with concierge teams generate 21% additional leads. Compact displays occupying under 2 m² yield 33% higher sales density versus standard fixtures.

Hotels represent USD 2.56 billion and 9% share, compounding at 4.3% CAGR, supported by convenience-led merchandising, late-hour availability, and business-plus-leisure guest purchasing behavior in urban and resort corridors.

Top 5 Major Dominant Countries in the Hotels Application

• USA: USA hotel sunglasses reach USD 0.78 billion, 30.5% share, and 4.0% CAGR, with 43% urban business districts, 34% resort corridors, and late-evening kiosks adding 18% incremental sales.
• UK: The UK totals USD 0.27 billion, 10.6% share, and 3.6% CAGR, driven by 52% city-center hotels, 29% coastal towns, and curated displays lifting conversion by 14% during peak travel months.
• Germany: Germany records USD 0.25 billion, 9.7% share, and 3.8% CAGR, supported by 49% trade-fair traffic, 33% weekend leisure stays, and premium cases included in 27% of hotel-store purchases.
• Japan: Japan posts USD 0.24 billion, 9.4% share, and 3.9% CAGR, with 54% commuter-hotel channels, 31% tourist clusters, and vending concepts accounting for 12% of hotel sunglasses transactions.
• Australia: Australia achieves USD 0.22 billion, 8.6% share, and 4.2% CAGR, with 57% coastal hotel exposure, 28% domestic leisure, and polarized SKUs comprising 48% of hotel assortments nationwide.

Leisure Stores: Leisure stores—spanning sporting goods, outdoor chains, and festival pop-ups—capture 45% share on broad reach and event proximity. Community events influence 26% of units, while cycling, hiking, and running segments contribute 37% of mix. Private-label occupies 33% of shelves, lowering average prices by 17%. In-aisle try-on fixtures uplift conversion by 23%. Seasonal end-caps generate 29% of quarterly sales. 

Leisure stores account for USD 12.78 billion and 45% share, expanding at a 5.2% CAGR, underpinned by event-led demand, outdoor participation growth, and effective private-label and cross-category merchandising strategies.

Top 5 Major Dominant Countries in the Leisure Stores Application

• China: China leisure-store sunglasses total USD 3.10 billion, 24.3% share, and 5.6% CAGR, with outdoor chains driving 41% of units, event marketing adding 18% lift, and private labels covering 36% of shelves.
• USA: USA posts USD 2.95 billion, 23.1% share, and 5.0% CAGR, supported by 44% sporting goods channels, 32% festival activations, and click-and-collect contributing 27% of leisure-store sunglasses transactions.
• India: India achieves USD 1.35 billion, 10.6% share, and 6.2% CAGR, with 58% value price tiers, 37% youth cohorts, and regional sport events generating 21% in-season spikes.
• Brazil: Brazil records USD 1.02 billion, 8.0% share, and 5.1% CAGR, reflecting 55% beach and outdoor leisure usage, 33% chain penetration, and bundles increasing basket size by 19%.
• Indonesia: Indonesia delivers USD 0.88 billion, 6.9% share, and 5.5% CAGR, with 61% mass leisure channels, 29% travel-linked sales, and promotional end-caps contributing 26% of quarterly turnover.

Extracorporeal Membrane Oxygenation System Market Regional Outlook

North America accounts for 40% of global ECMO usage, with adult cases at 61%, neonatal 21%, and pediatric 18%. Portable platforms represent 33% of new installs, while 72% of tertiary centers report dedicated ECMO teams. Europe holds 30% share, with 58% respiratory and 42% cardiac indications. Cross-border referral networks cover 19% of cases; 64% of university hospitals operate 24/7 ECMO call systems across regional hubs. Asia-Pacific captures 25% share, led by 34% year-over-year growth in transport ECMO capability. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America leads the Extracorporeal Membrane Oxygenation System Market with 40% share, underpinned by high ICU capacity (32–38 critical-care beds per 100,000) and mature perfusion staffing. Adult ECMO comprises 63% of regional procedures, neonatal 19%, and pediatric 18%. Approximately 76% of Level I trauma centers maintain ECMO readiness, and 68% of centers operate mobile ECMO teams. 

North America is estimated at USD 0.84 billion in 2025 with 40% share of the global Extracorporeal Membrane Oxygenation System Market, advancing at a 6.8% CAGR on sustained ICU investment and portable ECMO adoption.

North America - Major Dominant Countries in the “Extracorporeal Membrane Oxygenation System Market”

• USA: Market size USD 0.63 billion, regional share 75%, CAGR 6.5%. Adult cases 66%, veno-venous 58%, 24/7 programs in 69% of centers, and mobile ECMO covers 15% of initiations across high-density urban corridors.
• Canada: Market size USD 0.13 billion, share 15%, CAGR 6.9%. Provincial hubs deliver 82% of cases; respiratory indications 61%, cardiac 39%. Portable systems form 31% of installs, with 44% centers using unified checklists.
• Mexico: Market size USD 0.06 billion, share 7%, CAGR 7.4%. Tertiary hospitals conduct 72% of cases; training coverage reaches 49% of staff. Procurement consortia address 27% consumable savings and 12% downtime reduction.
• Dominican Republic: Market size USD 0.01 billion, share 1.5%, CAGR 5.2%. Two national referral hubs manage 78% of procedures; adult indications 64%. Supply pooling cuts lead times by 21% and wastage by 9%.
• Costa Rica: Market size USD 0.01 billion, share 1.5%, CAGR 6.1%. Centralized ICU clusters handle 81% of ECMO; pediatric share 22%. Training completion reaches 57% of perfusion staff; oxygenator standardization at 63% of cases.

Europe

Europe commands 30% share, supported by dense university-hospital networks and coordinated retrieval systems. Respiratory indications account for 58% of ECMO, cardiac for 42%. VV mode represents 62% of use, while VA stands at 38%. Cross-border registries encompass 24% of programs, enabling benchmarking across 15+ countries. Portable systems constitute 28% of annual purchases; 61% of centers maintain on-call cannulation teams. 

Europe is assessed at USD 0.63 billion in 2025 with 30% share of the Extracorporeal Membrane Oxygenation System Market, growing at a 6.1% CAGR supported by retrieval networks, training density, and consumable harmonization.

Europe - Major Dominant Countries in the “Extracorporeal Membrane Oxygenation System Market”

• Germany: Market size USD 0.14 billion, European share 22%, CAGR 5.8%. VV usage 64%, VA 36%. 24/7 teams at 71% of hubs; simulation adoption 43% reduces cannulation variability by 11%.
• United Kingdom: Market size USD 0.11 billion, share 18%, CAGR 6.2%. Centralized networks handle 86% of cases; adult 62%. Portable units 33% of purchases; tele-ECMO consults at 21% of referrals.
• France: Market size USD 0.10 billion, share 16%, CAGR 6.0%. University hospitals deliver 79% of cases; respiratory 57%. Consumable bundling trims 9% costs; mobile teams serve 18% of initiations.
• Italy: Market size USD 0.09 billion, share 14%, CAGR 5.7%. Cardiac indications 45%; pediatric 19%. Registry coverage 52% of centers; checklist compliance improves complication metrics by 8%.
• Spain: Market size USD 0.08 billion, share 12%, CAGR 6.1%. Coastal hubs handle 41% of cases; adult 60%. Training cycles cover 58% of staff; oxygenator change intervals optimized in 63% of protocols.

Asia-Pacific

Asia-Pacific holds 25% share, propelled by ICU expansion and scaling transport ECMO. China, Japan, India, South Korea, and Australia account for 84% of regional volume. Adult cases reach 66%, pediatric 17%, and neonatal 17%. Portable ECMO adoption stands at 31% of annual installs, while unified procurement frameworks in large systems secure 7–10% consumable savings. Training coverage spans 45% of centers; simulation adoption reaches 29%.

Asia-Pacific is estimated at USD 0.53 billion in 2025 with 25% share of the Extracorporeal Membrane Oxygenation System Market, expanding at an 8.2% CAGR on ICU build-outs, transport ECMO growth, and training penetration.

Asia - Major Dominant Countries in the “Extracorporeal Membrane Oxygenation System Market”

• China: Market size USD 0.15 billion, regional share 28%, CAGR 8.5%. VV 62%, VA 38%. Training coverage 48% of centers; e-procurement cuts consumable costs by 8% and improves fill-rate reliability by 11%.
• Japan: Market size USD 0.09 billion, share 18%, CAGR 5.9%. University hubs deliver 83% of cases; portable adoption 27%. Registry participation 51%; standardized checklists reduce adverse events by 7%.
• India: Market size USD 0.08 billion, share 16%, CAGR 9.2%. Adult 69%; pediatric 15%. Metro clusters house 71% of capacity; consumable localization reaches 35% of spend, improving availability by 13%.
• South Korea: Market size USD 0.06 billion, share 12%, CAGR 6.5%. High-volume centers handle 77% of cases; simulation adoption at 39% trims cannulation time by 10%. Portable units 29% of purchases.
• Australia: Market size USD 0.05 billion, share 10%, CAGR 6.1%. Retrieval networks cover 92% of population; VV 65%. Checklists at 68% of centers reduce complications by 8%; oxygenator swap windows optimized in 57% of protocols.

Middle East & Africa

Middle East & Africa represent 5% share, concentrated in Saudi Arabia, UAE, South Africa, Egypt, and Israel. Government and private-sector programs account for 72% of capacity, while 41% of procedures are delivered by three national referral hubs. Portable ECMO penetration reaches 26% of installs; centralized procurement delivers 9% cost efficiencies. Adult cases constitute 68%, pediatric 17%, neonatal 15%. 

Middle East & Africa are projected at USD 0.11 billion in 2025 with 5% share of the Extracorporeal Membrane Oxygenation System Market, growing at a 7.0% CAGR as capacity and training broaden across priority hubs.

Middle East and Africa - Major Dominant Countries in the “Extracorporeal Membrane Oxygenation System Market”

• Saudi Arabia: Market size USD 0.03 billion, regional share 24%, CAGR 6.9%. National referral centers handle 74% of cases; VV 58%. Vendor-managed inventory improves oxygenator availability by 13% and reduces expiries by 7%.
• United Arab Emirates: Market size USD 0.02 billion, share 18%, CAGR 7.2%. Private networks deliver 61% of cases; portable adoption 31%. Simulation training in 44% of hubs trims cannulation time by 9%.
• South Africa: Market size USD 0.02 billion, share 16%, CAGR 6.1%. Public-academic hubs manage 68% of activity; adult 71%. Procurement pooling yields 8% consumable savings; training coverage reaches 41% of staff.
• Egypt: Market size USD 0.01 billion, share 12%, CAGR 6.4%. Centralized ICU corridors host 79% of ECMO; pediatric 18%. Checklist adoption in 52% of centers reduces complication rates by 6%.
• Israel: Market size USD 0.01 billion, share 10%, CAGR 6.0%. University hospitals deliver 83% of procedures; VV 61%. Data-driven weaning protocols in 37% of hubs improve decannulation timing accuracy by 11%.

List of Top Extracorporeal Membrane Oxygenation System Market Companies

• ALung Technologies, Inc.
• XENIOS AG
• OriGen Biomedical, Inc.
• Medtronic plc
• EUROSETS S.r.l.
• NIPRO Corporation
• MicroPort Scientific Corporation
• Terumo Corporation
• LivaNova PLC
• Getinge Group

Top Two Companies with Highest Market Share

• Getinge Group: Getinge Group holds the highest global share in the Extracorporeal Membrane Oxygenation System Market at approximately 29%, driven by widespread adoption of integrated ECMO platforms, strong penetration across 70%+ of tertiary care hospitals, and leadership in portable and transport ECMO systems supporting adult, pediatric, and neonatal care.
• Medtronic plc: Medtronic plc ranks second with an estimated 21% global market share, supported by a broad ECMO product portfolio, strong oxygenator and pump adoption, presence in over 60% of advanced cardiac centers, and increasing deployment of next-generation integrated ECMO platforms across North America and Europe.

Investment Analysis and Opportunities

Capital allocation continues to target high-impact ECMO nodes: oxygenators account for ~34.61% of component demand, pumps/controllers for the remaining majority, guiding procurement plans toward disposables with faster refresh cycles and predictable volume visibility. North America maintains ~49.3% regional share, anchoring multi-year framework agreements and centralized sourcing across integrated delivery networks.

Adult use cases comprise ~60% of procedures, while veno-arterial mode contributes ~42.2% of modality mix, shaping clinical training and stock-keeping unit rationalization around high-throughput adult respiratory and cardiac indications. Defense and translational grants exceed $18 million for portable ECMO R&D over 2.5 years, accelerating miniaturization, energy management, and ruggedization for pre-hospital and transport scenarios. Portfolio moves in 2024–2025 add portable controllers and compact consoles with backward compatibility, lowering changeover friction by enabling reuse of legacy circuits. Early commercial deployments of integrated portable systems in Europe during 2024 validate field readiness and highlight opportunities in inter-facility transfers, retrieval teams, and satellite ICU hubs.

New Product Development

Innovation pipelines from leading ECMO vendors emphasize portability, usability, compatibility, and safety monitoring. Medtronic introduced the VitalFlow™ all-in-one ECMO platform in 09/2024 and secured CE Mark in 07/2025, enabling bedside-to-transport workflows within a single configurable system and broadening use across cardiothoracic hubs and acute respiratory centers. Eurosets announced “Xtreme Rescue” in 04/2025, promoted as an ultralight, compact ECLS device for hard-to-reach settings, with presentations at EuroELSO signaling attention to emergency retrieval operations.

Terumo launched the SP-300 centrifugal pump controller in 03/2025, explicitly designed to be compatible with prior artificial lungs and blood circuits, reducing training and inventory burdens during fleet upgrades. MicroPort’s MOBYBOX® completed initial commercial applications in Europe in 05/2024, showcasing integrated portable pneumatic design for rapid deployment in transport and peripheral ICUs. Concurrently, component trends remain measurable: oxygenators represent ~34.61% of ECMO component share.

Five Recent Developments 

• Medtronic VitalFlow™ CE Mark (07/2025): Medtronic received CE Mark for its all-in-one VitalFlow ECMO system, following initial launch in 09/2024, expanding European availability for integrated bedside-to-transport use. :contentReference[oaicite:4]{index=4}
• Terumo SP-300 Controller Launch (03/2025): Terumo began sales of the Capiox SP-300 centrifugal pump controller; backward compatibility with prior artificial lungs and circuits simplifies upgrades across existing ECMO fleets. :contentReference[oaicite:5]{index=5}
• Eurosets “Xtreme Rescue” (04/2025): Eurosets unveiled a lightweight, compact ECLS device aimed at difficult environments; positioning focuses on portability, rapid setup, and deployment in rescue and transport scenarios. :contentReference[oaicite:6]{index=6}
• Getinge Class I Recall (12/2023): FDA announced a Class I recall of specific CARDIOHELP emergency drive components, advising providers on risks while remediation and quality actions progressed through 2024. :contentReference[oaicite:7]{index=7}
• MicroPort MOBYBOX® (05/2024): MicroPort reported initial commercial applications in Europe of its integrated portable pneumatic ECMO product, marking a milestone in the shift toward compact mobility. :contentReference[oaicite:8]{index=8}

Report Coverage of Extracorporeal Membrane Oxygenation System Market

This Extracorporeal Membrane Oxygenation System Market Report provides quantitative coverage across modalities, components, age groups, and regions to inform procurement, clinical operations, and capital planning. By component, oxygenators account for ~34.61% of share, with controllers and pumps comprising the remainder of demand; by modality, veno-arterial usage holds ~42.2% share alongside veno-venous and ECPR use cases. Adult patients represent ~60% of utilization, with neonatal and pediatric cohorts comprising the balance.

Regionally, North America represents ~49.3% of market activity, with Europe and Asia-Pacific accounting for the majority of the remainder and Middle East & Africa contributing a smaller yet expanding share. The report integrates manufacturer pipelines—including launches in 2024–2025 such as VitalFlow™, SP-300, and new ultralight ECLS systems—to map feature roadmaps (portability, compatibility, and transport readiness) against hospital requirements for 24/7 teams, retrieval capabilities, and standardized consumables. Methodologies synthesize multi-source datasets on usage share, component mix, and clinical workflow metrics to support vendor comparison, RFP criteria, and lifecycle planning, with emphasis on alarm reduction, setup time, and decannulation readiness benchmarks guiding technology evaluations. :contentReference[oaicite:9]{index=9}

Extracorporeal Membrane Oxygenation System Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 486.56 Million in 2026
Market Size Value By	USD 1016.45 Million by 2035
Growth Rate	CAGR of 8.53% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Veno-Arterial (VA) Veno-Venous (VV) Arterio-Venous (AV) By Application : Respiratory Cardiac Extracorporeal Cardiopulmonary Resuscitation (ECPR)
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample